Article, 2024

Dilarmycins A-C, Calcium-Dependent Lipopeptide Antibiotics with a Non-canonical Ca-Binding Motif

Organic Letters, ISSN 1523-7060, Volume 26, 7, Pages 1343-1347, 10.1021/acs.orglett.3c04195

Contributors

Fernandez-Pastor I. [1] Ortiz-Lopez F.J. 0000-0002-9410-3718 (Corresponding author) [1] Oves-Costales D. 0000-0001-9986-4623 (Corresponding author) [1] Martin J. [1] Sanchez P. [1] Melguizo A. [1] Reyes F. 0000-0003-1607-5106 [1] Weber T. 0000-0002-8260-5120 [2] Genilloud O. 0000-0002-4202-1219 [1]

Affiliations

  1. [1] FundaciĆ³n MEDINA
  2. [NORA names: Spain; Europe, EU; OECD];
  3. [2] Technical University of Denmark
  4. [NORA names: DTU Technical University of Denmark; University; Denmark; Europe, EU; Nordic; OECD]

Abstract

Genome analysis of strain Streptomyces sp. CA-278952 revealed a biosynthetic gene cluster encoding a putative lipopeptide with a sequence containing an Asp-Gly-Glu-Ala motif. We envisioned that this motif could mimic the canonical Asp-X-Asp-Gly sequence found in previously reported calcium-dependent lipopeptide antibiotics. Chemical investigation of the producing strain led to the discovery of three novel lipodepsipeptides, dilarmycins A-C. The calcium-dependent antibacterial activity of the new compounds was confirmed against the Gram-positive pathogens methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.

Funders

  • Novo Nordisk Fonden

Data Provider: Elsevier